 "US pharma firms speed up work on coronavirus vaccine: Donald Trump")
Some of the American pharmaceutical companies have speed up their work towards finding a vaccine for the new coronavirus strain, President Donald Trump said on Monday, ahead of a meeting with executives of drug companies.
"I'm meeting with the pharmaceutical companies later on this afternoon. We have a big meeting with the biggest companies...we're talking about a vaccine... maybe a cure; it's possible. So, we'll see about that," Trump told reporters in the Oval Office of the White House.
"We're talking about a vaccine. They are moving along very quickly. All pharmaceutical companies are moving along very quickly," he said.
The US so far has reported 80 cases of infection and two deaths from COVID-19, which was first detected in China in December.
The US, Trump said, is working with other countries to find vaccine for the novel coronavirus.
"We're working very much with a lot of other countries on -- including Colombia -- but we're working with a lot of other countries on helping them with respect to this problem. And, again, we're doing very well," he said in the presence of his Columbian counterpart.
"I'm meeting with the pharmaceutical companies later on this afternoon. We have a big meeting with the biggest companies...we're talking about a vaccine... maybe a cure; it's possible. So, we'll see about that," Trump told reporters in the Oval Office of the White House.
"We're talking about a vaccine. They are moving along very quickly. All pharmaceutical companies are moving along very quickly," he said.
The US so far has reported 80 cases of infection and two deaths from COVID-19, which was first detected in China in December.
The US, Trump said, is working with other countries to find vaccine for the novel coronavirus.
"We're working very much with a lot of other countries on -- including Colombia -- but we're working with a lot of other countries on helping them with respect to this problem. And, again, we're doing very well," he said in the presence of his Columbian counterpart.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%